Journal profile · Immunology
Genes and Immunity
ISSN 1466-4879 · eISSN 1476-5470 · Springer Nature · ENGLAND · Bimonthly · Founded 1999
Genes and Immunity: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.21; hybrid open access; APC about USD 3,190; median 211 days to acceptance (94 articles, last 24 months); community-reported acceptance: moderate; 56 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Genes and Immunity is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immune Cell Function and Interaction and Systemic Lupus Erythematosus Research, together about 37.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Genes & Immunity emphasizes studies investigating how genetic, genomic and functional variations affect immune cells and the immune system, and associated processes in the regulation of health and disease. It further highlights articles on the transcriptional and posttranslational control of gene products involved in signaling pathways regulating immune cells, and protective and destructive immune responses.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology15.8%
- Immune Cell Function and InteractionImmunology and Microbiology15%
- Systemic Lupus Erythematosus ResearchMedicine7%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.4%
- Immune Response and InflammationImmunology and Microbiology6.1%
- Cytokine Signaling Pathways and InteractionsMedicine4.9%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology4.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Immunology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, ANVUR, BIOSIS, CNPIEC, Cortellis Drug Discovery Intelligence, EMBiology, Gale, Japanese Science and Technology Agency (JST), Meta, OCLC WorldCat Discovery Service, Ovid Discovery, Pathway Studio, SCImago, TD Net Discovery Service, Wanfang, eLibrary.ru
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.21LetPub ·
- Impact factor (publisher) 2025
- 4.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.5Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 1.34LetPub ·
- SJR (publisher) 2025
- 1.34Publisher website ·
- SNIP 2026-06
- 0.82LetPub ·
- SNIP (publisher) 2025
- 0.82Publisher website ·
- h-index
- 95LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 1,443OpenAlex ·
- 2-year mean citedness
- 3.89OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 39.55%LetPub ·
Volume
- Articles per year
- 54LetPub ·
- Downloads per year (publisher) 2025
- 607,792Publisher website ·
Articles by year OpenAlex count · 1,957 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 18 | 28 |
| 2025 | 56 | 26 | 172 |
| 2024 | 68 | 32 | 442 |
| 2023 | 55 | 32 | 533 |
| 2022 | 32 | 20 | 776 |
| 2021 | 40 | 29 | 1,550 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
211 daysMedian, submission to acceptance · P25–P75 152 days – 282 days
- Acceptance to online
- median 15 days (94 articles)
- Submission to online
- median 233 days
- Sample
- 94 articles with submission and acceptance dates (114 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 15 daysPublisher website ·
- Submission to acceptance
- 227 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,190 / EUR 5,190 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- articleArticleLength not stated
- commentCommentLength not stated
Policy excerpts from the journal's websiteOpen access
- Open access
Gold open access possible with manifold funding options available. Model summary
Gold OA possible; manifold funding options available.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1999
- ISSN
- 1466-4879
- Electronic ISSN
- 1476-5470
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Genes and Immunity
What CAS zone is Genes and Immunity in?
In the 2025 upgraded edition of the CAS Journal Ranking, Genes and Immunity is in Zone 3 of Medicine, and in Zone 3 of the minor category Genetics & Heredity / Immunology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Genes and Immunity?
The latest impact factor listed by LetPub is 4.21; CiteScore 5.9, h-index 128.
How long does peer review take at Genes and Immunity?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 211 days (interquartile range 152–282 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Genes and Immunity?
According to LetPub and DOAJ records, Genes and Immunity is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and CAB Abstracts; that list has not been checked against each database.
Is Genes and Immunity open access, and what is the APC?
Genes and Immunity is a hybrid journal. For open-access publication: APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .